321 related articles for article (PubMed ID: 19446755)
1. Slow-release system of pegylated lysozyme utilizing formation of polypseudorotaxanes with cyclodextrins.
Higashi T; Hirayama F; Yamashita S; Misumi S; Arima H; Uekama K
Int J Pharm; 2009 Jun; 374(1-2):26-32. PubMed ID: 19446755
[TBL] [Abstract][Full Text] [Related]
2. Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release system.
Higashi T; Hirayama F; Arima H; Uekama K
Bioorg Med Chem Lett; 2007 Apr; 17(7):1871-4. PubMed ID: 17291751
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system.
Higashi T; Hirayama F; Misumi S; Arima H; Uekama K
Biomaterials; 2008 Oct; 29(28):3866-71. PubMed ID: 18620750
[TBL] [Abstract][Full Text] [Related]
4. Polypseudorotaxane formation of randomly-pegylated insulin with cyclodextrins: slow release and resistance to enzymatic degradation.
Higashi T; Hirayama F; Misumi S; Motoyama K; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2009 May; 57(5):541-4. PubMed ID: 19420793
[TBL] [Abstract][Full Text] [Related]
5. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA.
Motoyama K; Hayashida K; Higashi T; Arima H
Bioorg Med Chem; 2012 Feb; 20(4):1425-33. PubMed ID: 22277591
[TBL] [Abstract][Full Text] [Related]
6. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin.
Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H
Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768
[TBL] [Abstract][Full Text] [Related]
7. Potential use of polypseudorotaxanes of pegylated polyamidoamine dendrimer with cyclodextrins as novel sustained release systems for DNA.
Motoyama K; Hayashida K; Arima H
Chem Pharm Bull (Tokyo); 2011; 59(4):476-9. PubMed ID: 21467677
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin/poly(ethylene glycol) polypseudorotaxane hydrogels as a promising sustained-release system for lysozyme.
Higashi T; Tajima A; Motoyama K; Arima H
J Pharm Sci; 2012 Aug; 101(8):2891-9. PubMed ID: 22678818
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone-α-cyclodextrin-star PEG polypseudorotaxanes with controlled drug delivery properties.
Bílková E; Sedlák M; Dvořák B; Ventura K; Knotek P; Beneš L
Org Biomol Chem; 2010 Dec; 8(23):5423-30. PubMed ID: 20859603
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of novel coumarin derivative functionalized polypseudorotaxane micelles for drug delivery.
Chang J; Li Y; Wang G; He B; Gu Z
Nanoscale; 2013 Jan; 5(2):813-20. PubMed ID: 23235914
[TBL] [Abstract][Full Text] [Related]
11. Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.
Higashi T; Tajima A; Ohshita N; Hirotsu T; Abu Hashim II; Motoyama K; Koyama S; Iibuchi R; Mieda S; Handa K; Kimoto T; Arima H
AAPS PharmSciTech; 2015 Dec; 16(6):1290-8. PubMed ID: 25776984
[TBL] [Abstract][Full Text] [Related]
12. More on polypseudorotaxanes formed between poly(ethylene glycol) and α-cyclodextrin.
Sabadini E; Egídio Fdo C; Cosgrove T
Langmuir; 2013 Apr; 29(15):4664-9. PubMed ID: 23510502
[TBL] [Abstract][Full Text] [Related]
13. One-pot synthesis of a polyrotaxane via selective threading of a PEI-b-PEG-b-PEI copolymer.
Choi HS; Ooya T; Yui N
Macromol Biosci; 2006 Jun; 6(6):420-4. PubMed ID: 16761273
[TBL] [Abstract][Full Text] [Related]
14. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
Müller E; Josic D; Schröder T; Moosmann A
J Chromatogr A; 2010 Jul; 1217(28):4696-703. PubMed ID: 20570270
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin-based sustained and controllable release system of insulin utilizing the combination system of self-assembly PEGylation and polypseudorotaxane formation.
Hirotsu T; Higashi T; Motoyama K; Arima H
Carbohydr Polym; 2017 May; 164():42-48. PubMed ID: 28325342
[TBL] [Abstract][Full Text] [Related]
16. Effect of enzyme modification by well-defined multi-armed poly(ethylene glycol) synthesized using polyamidoamine dendron.
Harada A; Kato T; Kawamura A; Kojima C; Kono K
J Biomater Sci Polym Ed; 2011; 22(12):1551-61. PubMed ID: 20810022
[TBL] [Abstract][Full Text] [Related]
17. Preparation of polypseudorotaxanes composed of cyclodextrin and polymers in microspheres.
Shinohara K; Yamashita M; Uchida W; Okabe C; Oshima S; Sugino M; Egawa Y; Miki R; Hosoya O; Fujihara T; Ishimaru Y; Kishino T; Seki T; Juni K
Chem Pharm Bull (Tokyo); 2014; 62(10):962-6. PubMed ID: 25273055
[TBL] [Abstract][Full Text] [Related]
18. Preparation of alpha-cyclodextrin-terminated polyrotaxane consisting of beta-cyclodextrins and pluronic as a building block of a biodegradable network.
Ooya T; Ito A; Yui N
Macromol Biosci; 2005 May; 5(5):379-83. PubMed ID: 15895475
[TBL] [Abstract][Full Text] [Related]
19. Noncovalent complexes between poly(ethylene glycol) and proteins.
Topchieva IN; Sorokina EM; Efremova NV; Ksenofontov AL
Biochemistry (Mosc); 1998 Nov; 63(11):1312-8. PubMed ID: 9864473
[TBL] [Abstract][Full Text] [Related]
20. α-chymotrypsin activated and stabilized by self-assembled polypseudorotaxane fabricated with bis-thiolated poly(ethylene glycol) and α-cyclodextrin: Spectroscopic and mechanistic analysis.
Zhao J; Lin JD; Chen JC; Chen G; Li XL; Wang XQ; Chen MX
Int J Biol Macromol; 2017 Sep; 102():1266-1273. PubMed ID: 28495630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
